Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 9664 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#9664, RRID:AB_2070042
- Product name
- Cleaved Caspase-3 (Asp175) (5A1E) Rabbit mAb
- Antibody type
- Monoclonal
- Reactivity
- Human, Mouse, Rat, Simian
- Host
- Rabbit
- Storage
- -20°C
Submitted references The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib.
Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function.
Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis.
CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101.
Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.
Yerlikaya A, Okur E, Ulukaya E
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Oct;33(5):1385-92
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Oct;33(5):1385-92
Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function.
Yoshioka K, Yoshida K, Cui H, Wakayama T, Takuwa N, Okamoto Y, Du W, Qi X, Asanuma K, Sugihara K, Aki S, Miyazawa H, Biswas K, Nagakura C, Ueno M, Iseki S, Schwartz RJ, Okamoto H, Sasaki T, Matsui O, Asano M, Adams RH, Takakura N, Takuwa Y
Nature medicine 2012 Oct;18(10):1560-9
Nature medicine 2012 Oct;18(10):1560-9
Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis.
Yilmaz M, Maass D, Tiwari N, Waldmeier L, Schmidt P, Lehembre F, Christofori G
The EMBO journal 2011 Sep 6;30(21):4489-99
The EMBO journal 2011 Sep 6;30(21):4489-99
CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101.
Jak M, van Bochove GG, Reits EA, Kallemeijn WW, Tromp JM, Umana P, Klein C, van Lier RA, van Oers MH, Eldering E
Blood 2011 Nov 10;118(19):5178-88
Blood 2011 Nov 10;118(19):5178-88
Bortezomib sensitizes malignant human glioma cells to TRAIL, mediated by inhibition of the NF-{kappa}B signaling pathway.
Jane EP, Premkumar DR, Pollack IF
Molecular cancer therapeutics 2011 Jan;10(1):198-208
Molecular cancer therapeutics 2011 Jan;10(1):198-208
No comments: Submit comment
No validations: Submit validation data